Use of adrenocorticosteroid hormones in the treatment of multiple sclerosis.

about

Use of adrenocorticosteroid hormones in the treatment of multiple sclerosis.

Item

http://www.wikidata.org/entity/Q48457492

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Use of adrenocorticosteroid hormones in the treatment of multiple sclerosis.

@en

Use of adrenocorticosteroid hormones in the treatment of multiple sclerosis.

@nl

type

Item

label

Use of adrenocorticosteroid hormones in the treatment of multiple sclerosis.

@en

Use of adrenocorticosteroid hormones in the treatment of multiple sclerosis.

@nl

prefLabel

Use of adrenocorticosteroid hormones in the treatment of multiple sclerosis.

@en

Use of adrenocorticosteroid hormones in the treatment of multiple sclerosis.

@nl

P1476

Use of adrenocorticosteroid hormones in the treatment of multiple sclerosis.

@en

P2093

Douglas R Jeffery

http://www.w3.org/2001/XMLSchema#string

P2860

Perils and pitfalls in the interpretation of clinical trials: a reflection on the recent experience in multiple sclerosis.

Intravenous methylprednisolone for multiple sclerosis in relapse.

Practice parameter: the role of corticosteroids in the management of acute monosymptomatic optic neuritis. Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Relationship between disease activity and dose-response relationships with beta interferon therapies in the treatment of multiple sclerosis.

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.

In vivo glucocorticoid modulation of guinea pig splenic macrophage Fc gamma receptors.

The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.

MRI aspects of secondary progressive multiple sclerosis.

Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose.

Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury.

P304

859-866

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737175.2.6.859

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2002-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19810919

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis